darzalex-conc-for-soln-for-iv-infusion-100-mg-5-ml
Darzalex conc for soln for IV infusion 100 mg/5 mL (100 mg/5 mL)
Manufacturer:
Johnson & Johnson
Contents:
daratumumab
MIMS Class:
Targeted Cancer Therapy
Form:
Vial
Shape:
Undefined
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement